No overhand and no need for cash for 2 years. Uplisting, Alzheimers, Epilepsy, Parkensons. MS etc etc. strong due diligence by Michael Fox foundation as wll. Stay tuned more coming !
Handle will lead up to September meeting.
" IT WAS AS IF A LIGHT WAS TURNED ON" Patients and families demanded an extention of the drug!!
Patients begging for these drugs.
that does not include all the money raised after the June quarter ended from warrants.
Revenues grew to 14 million up from 10 last quarter..facts,
math says most have been exercised and sold. My guess is little overhang left and thus going higher !!
Yes that includes all warrants. This is dirt cheap. $10 gives just a 1.6m market cap not close to the billions other biotech with faulty alzheiners have.
Oragenics’ new lead clinical candidate achieved a 100% survival rate throughout the entire study in contrast to a 33% survival rate for the vancomycin (current standard of care) positive control. There was a 0% survival rate for the placebo control group.
Natural Killer Cells in your own immune system !